The same study demonstrated that peroxiredoxin-4 (PRDX-4) is also implicated in this process, and that higher levels of both L-plastin and PRDX-4 are associated with a higher risk to develop bone metastasis in breast cancer patients [76]. Here, PRDX4 is linked to bone metastasis.